The Recombinant Proteins Manufacturing market is a subset of the biopharmaceuticals industry, which focuses on the production of proteins through recombinant DNA technology. This technology involves the insertion of a gene from one organism into another, allowing for the production of proteins that are not naturally found in the organism. These proteins can be used for a variety of medical applications, such as the treatment of diseases, the development of vaccines, and the production of diagnostic tests. The Recombinant Proteins Manufacturing market is highly competitive, with a number of companies offering a range of products and services. Companies in this market include Lonza, Merck KGaA, Novozymes, and Thermo Fisher Scientific. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
